• About
  Cedars-Sinai
• Careers at
  Cedars-Sinai
• Giving
  & Support
• Health
  Conditions
• Healthcare
  Professionals
• Patients
  & Visitors
• Programs
  & Services
• Quality
  Measures
• Research &
  Education

Cedars-Sinai Heart Institute is currently conducting the following dyslipidemia clinical trials:

• A Phase III Clinical Trial of the Efficacy and Safety of Torcetrapib/Atorvastatin vs. Ezitimibe/Simvastatin

• LDL Apheresis Registry

Principal Investigator: P.K. Shah, MD

IRB Approval Number: 8478

Contact: Mitch Gheorghiu (310) 423-6152

Recruiting

Principal Investigator: Donna Polk, MD

IRB Approval Number: 3113

Contact: (310) 423-9660

Recruiting